NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $75,000 | +5.6% | 4,205 | +1.3% | 0.00% | +100.0% |
| Q2 2021 | $71,000 | -13.4% | 4,150 | +0.7% | 0.00% | -50.0% |
| Q1 2021 | $82,000 | +17.1% | 4,120 | -0.6% | 0.00% | 0.0% |
| Q4 2020 | $70,000 | +180.0% | 4,145 | +171.3% | 0.00% | +100.0% |
| Q3 2020 | $25,000 | -51.0% | 1,528 | +81.0% | 0.00% | -66.7% |
| Q3 2018 | $51,000 | -95.6% | 844 | -96.4% | 0.00% | -95.9% |
| Q2 2018 | $1,153,000 | – | 23,631 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |